KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Neurological Disorders
The KIF1C Gene Spastic Ataxia Type 2 Autosomal Recessive NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with hereditary spastic ataxia. This advanced testing methodology provides crucial insights for patients and families affected by progressive movement disorders, enabling early intervention and informed medical decision-making.
What This Test Measures and Detects
This sophisticated genetic analysis specifically targets the KIF1C gene, which encodes a kinesin motor protein essential for intracellular transport in neuronal cells. The test utilizes Next-Generation Sequencing (NGS) technology to identify:
- Pathogenic variants in the KIF1C gene associated with autosomal recessive spastic ataxia type 2
- Single nucleotide polymorphisms (SNPs) affecting protein function
- Insertion/deletion mutations disrupting normal gene expression
- Compound heterozygous mutations requiring inheritance from both parents
- Carrier status identification for family planning purposes
Who Should Consider This Genetic Test
This specialized neurological genetic test is recommended for individuals experiencing:
- Progressive gait disturbances and balance problems
- Muscle stiffness and spasticity in lower extremities
- Coordination difficulties affecting daily activities
- Family history of hereditary ataxia or spastic paraplegia
- Unexplained neurological symptoms with childhood or adolescent onset
- Consanguineous parentage increasing recessive disorder risk
- Previous inconclusive neurological evaluations
Clinical Benefits of KIF1C Genetic Testing
Undergoing this comprehensive genetic analysis provides multiple significant advantages:
- Accurate Diagnosis: Confirms or rules out KIF1C-related spastic ataxia with high precision
- Family Planning Guidance: Identifies carrier status and recurrence risks for future generations
- Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
- Prognostic Information: Provides insights into disease progression and expected symptom patterns
- Early Intervention: Facilitates timely implementation of physical therapy and supportive care
- Psychological Relief: Reduces diagnostic uncertainty and provides clear answers
Understanding Your Test Results
Your genetic test report will provide comprehensive information about your KIF1C gene status:
- Positive Result: Indicates pathogenic mutations confirming spastic ataxia type 2 diagnosis
- Negative Result: Suggests alternative causes for neurological symptoms requiring further evaluation
- Carrier Status: Identifies individuals with single mutation copy who are typically asymptomatic
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
All results are accompanied by detailed interpretation from our certified genetic counselors and neurologists, ensuring you receive comprehensive guidance for next steps and management strategies.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Accessibility
We maintain comprehensive testing facilities across major metropolitan areas throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures convenient access to this specialized neurological genetic testing regardless of your location.
Take Control of Your Neurological Health Today
Don’t let uncertainty about hereditary neurological conditions affect your quality of life. Our expert team of genetic counselors and neurologists is ready to provide the answers and guidance you need. Schedule your KIF1C Gene Spastic Ataxia Type 2 NGS Genetic DNA Test today and take the first step toward definitive diagnosis and personalized care.
Call or WhatsApp us now at +1(267) 388-9828 to book your appointment or request additional information about this essential neurological genetic screening.
